Terrie Curran
2022
In 2022, Terrie Curran earned a total compensation of $5M as President and Chief Executive Officer at Phathom Pharmaceuticals, a 20% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $442,358 |
|---|---|
| Option Awards | $3,932,145 |
| Salary | $650,000 |
| Other | $15,375 |
| Total | $5,039,878 |
Curran received $3.9M in option awards, accounting for 78% of the total pay in 2022.
Curran also received $442.4K in non-equity incentive plan, $650K in salary and $15.4K in other compensation.
Rankings
In 2022, Terrie Curran's compensation ranked 631st out of 5,756 executives tracked by ExecPay. In other words, Curran earned more than 89.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 631 out of 5,756 | 89th |
Division Manufacturing | 272 out of 3,133 | 91st |
Major group Chemicals And Allied Products | 85 out of 1,419 | 94th |
Industry group Drugs | 72 out of 1,320 | 95th |
Industry Pharmaceutical Preparations | 53 out of 966 | 95th |
Source: SEC filing on April 13, 2023.
Curran's colleagues
We found two more compensation records of executives who worked with Terrie Curran at Phathom Pharmaceuticals in 2022.
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
Phathom Pharmaceuticals CEO Terrie Curran's 2020 pay jumps 34% to $4.6M
April 6, 2021
Phathom Pharmaceuticals CEO Terrie Curran receives $3.5M in 2019
April 8, 2020